Diabetes

Review Details Relationship Between Frailty, Diabetes in Older Populations

December 22nd 2020, 3:00pm

Article

The identification and assessment of frailty, defined as a state of increased vulnerability to adverse health outcomes resulting from loss of physiological reserve, should become a routine aspect of diabetes care, authors of a systematic review and meta-analysis published in The Lancet Health Longevity argued.

Empagliflozin Linked to 20% Drop in Care Costs for T2D, CVD

December 15th 2020, 10:30pm

Article

An outcomes-based agreement conducted by Boehringer Ingelheim and Highmark found that use of Jardiance (empagliflozin) among adults with type 2 diabetes (T2D) and known cardiovascular disease (CVD) was associated with a total cost of care savings of over 20%.

Poxel's PXL770 Shows Promise in Patients With NASH, T2D

December 14th 2020, 5:00pm

Article

Results from a phase 2 trial show PXL770 yielded consistently greater responses in high-risk patients with comorbid nonalcoholic steatohepatitis (NASH) and type 2 diabetes (T2D) compared with placebo.

Metformin Linked to Lower COVID-19 Mortality Rates Among Women With T2D, Obesity

December 8th 2020, 10:15pm

Article

Among women hospitalized with coronavirus disease 2019 (COVID-19), use of metformin—a type 2 diabetes (T2D) drug used to manage blood sugar levels—was associated with a 21.5% lower risk of death.

Experts Discuss Benefits, Limitations of Pediatric Obesity Interventions

December 7th 2020, 5:46pm

Article

During a session at the at the 18th annual World Congress Insulin Resistance, Diabetes & Cardiovascular Disease presented by the Metabolic Institute of America, experts outlined the benefits and limitations of pharmacological, surgical, and lifestyle interventions for pediatric patients with obesity.

Dr Paul Zimmet Outlines COVID-19, Diabetes Challenges and Lessons Learned From the Pandemic

December 4th 2020, 6:42pm

Article

In a session at the 18th annual World Congress Insulin Resistance, Diabetes & Cardiovascular Disease presented by the Metabolic Institute of America, experts discussed challenges faced by patients with diabetes in the wake of the coronavirus disease 2019 (COVID-19) pandemic and lessons learned from the crisis.

Database Helps Clinicians Determine Whether COVID-19 Causes Diabetes

December 1st 2020, 6:15pm

Podcast

In this episode of Managed Care Cast, Francesco Rubino, MD, discusses the potential bidirectional relationship between coronavirus disease 2019 (COVID-19) and diabetes.

Kentucky Telemedicine Program Increases Diabetic Retinopathy Screening Rates

November 28th 2020, 5:00pm

Article

Large telemedicine diabetic retinopathy screening networks based in federally designated safety-net clinics may be able to increase screening access and compliance among otherwise underscreened populations.

Study Highlights Racial Disparities in T1D Pediatric Population

November 26th 2020, 2:00pm

Article

Regardless of insurance status, racial disparities in technology use and diabetes outcomes persist in children with type 1 diabetes (T1D), according to a recent study.

NDPS Data Show Minor Weight Loss Can Almost Halve T2D Risk

November 18th 2020, 2:00pm

Article

For individuals currently in high-risk glycemic categories, losing 2 to 3 kg (4.5-6.5 lb) in combination with increased physical activity over 2 years nearly halved the risk of developing type 2 diabetes (T2D).